CME Financial Statements (CME)
|
|
|
|
Report date
|
|
|
25.02.2022 |
31.12.2022 |
27.02.2023 |
31.12.2023 |
28.02.2024 |
|
08.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 690 |
5 019 |
5 019 |
5 579 |
5 579 |
|
6 234 |
|
Operating Income, bln rub |
|
|
2 645 |
3 016 |
3 016 |
3 436 |
3 436 |
|
4 050 |
|
EBITDA, bln rub |
? |
|
2 990 |
4 016 |
3 365 |
3 788 |
3 788 |
|
4 259 |
|
Net profit, bln rub |
? |
|
2 636 |
2 691 |
2 691 |
3 186 |
3 226 |
|
3 514 |
|
|
OCF, bln rub |
? |
|
2 402 |
|
3 056 |
705.2 |
3 454 |
|
1 780 |
|
CAPEX, bln rub |
? |
|
127.2 |
|
89.7 |
0.000 |
76.4 |
|
48.0 |
|
FCF, bln rub |
? |
|
2 275 |
|
2 966 |
705.2 |
3 377 |
|
1 732 |
|
Dividend payout, bln rub
|
|
|
2 189 |
|
2 634 |
0.000 |
3 236 |
|
837.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
83.0% |
0.00% |
97.9% |
0.00% |
100.3% |
|
23.8% |
|
|
OPEX, bln rub |
|
|
1 208 |
1 250 |
1 250 |
1 105 |
1 105 |
|
934.2 |
|
Cost of production, bln rub |
|
|
837.0 |
753.1 |
753.1 |
1 039 |
1 039 |
|
1 291 |
|
R&D, bln rub |
|
|
192.6 |
0.000 |
188.6 |
0.000 |
0.000 |
|
187.6 |
|
Interest expenses, bln rub |
|
|
166.9 |
162.7 |
162.7 |
159.4 |
159.4 |
|
160.3 |
|
|
Assets, bln rub |
|
|
196 780 |
174 176 |
174 176 |
129 706 |
129 706 |
|
137 795 |
|
Net Assets, bln rub |
? |
|
27 399 |
26 879 |
26 879 |
26 738 |
26 738 |
|
28 216 |
|
Debt, bln rub |
|
|
3 445 |
3 438 |
3 438 |
3 425 |
3 884 |
|
3 427 |
|
Cash, bln rub |
|
|
2 950 |
2 816 |
2 816 |
3 029 |
3 024 |
|
2 434 |
|
Net debt, bln rub |
|
|
495.2 |
622.3 |
622.3 |
396.5 |
860.2 |
|
993.0 |
|
|
Ordinary share price, rub |
|
|
228.5 |
168.2 |
168.2 |
210.6 |
210.6 |
|
212.5 |
|
Number of ordinary shares, mln |
|
|
358.3 |
357.8 |
358.7 |
359.5 |
359.0 |
|
359.4 |
|
|
Market cap, bln rub |
|
|
81 866 |
60 162 |
60 321 |
75 711 |
75 610 |
|
76 383 |
|
EV, bln rub |
? |
|
82 362 |
60 784 |
60 943 |
76 107 |
76 470 |
|
77 376 |
|
Book value, bln rub |
|
|
-3 836 |
-4 049 |
-4 049 |
16 243 |
-3 983 |
|
527 |
|
|
EPS, rub |
? |
|
7.36 |
7.52 |
7.50 |
8.86 |
8.99 |
|
9.78 |
|
FCF/share, rub |
|
|
6.35 |
0.00 |
8.27 |
1.96 |
9.41 |
|
4.82 |
|
BV/share, rub |
|
|
-10.7 |
-11.3 |
-11.3 |
45.2 |
-11.1 |
|
1.47 |
|
|
EBITDA margin, % |
? |
|
63.8% |
80.0% |
67.0% |
67.9% |
67.9% |
|
68.3% |
|
Net margin, % |
? |
|
56.2% |
53.6% |
53.6% |
57.1% |
57.8% |
|
56.4% |
|
FCF yield, % |
? |
|
2.78% |
0.00% |
4.92% |
0.93% |
4.47% |
|
2.27% |
|
ROE, % |
? |
|
9.62% |
10.0% |
10.0% |
11.9% |
12.1% |
|
12.5% |
|
ROA, % |
? |
|
1.34% |
1.54% |
1.54% |
2.46% |
2.49% |
|
2.55% |
|
|
P/E |
? |
|
31.1 |
22.4 |
22.4 |
23.8 |
23.4 |
|
21.7 |
|
P/FCF |
|
|
36.0 |
|
20.3 |
107.4 |
22.4 |
|
44.1 |
|
P/S |
? |
|
17.5 |
12.0 |
12.0 |
13.6 |
13.6 |
|
12.3 |
|
P/BV |
? |
|
-21.3 |
-14.9 |
-14.9 |
4.66 |
-19.0 |
|
145.0 |
|
EV/EBITDA |
? |
|
27.5 |
15.1 |
18.1 |
20.1 |
20.2 |
|
18.2 |
|
Debt/EBITDA |
|
|
0.17 |
0.15 |
0.18 |
0.10 |
0.23 |
|
0.23 |
|
|
R&D/CAPEX, % |
|
|
151.4% |
|
210.3% |
|
0.00% |
|
390.8% |
|
|
CAPEX/Revenue, % |
|
|
2.71% |
0.00% |
1.79% |
0.00% |
1.37% |
|
0.77% |
|
| CME shareholders |
